Skip to main content
Log in

Expression of caveolin-1 and MMP-2 in bladder cancer and its clinical significance

  • Published:
The Chinese-German Journal of Clinical Oncology

Abstract

Objective

To explore the expression of caveolin-1 (CAV-1) and matrix metalloproteinase-2 (MMP-2) in bladder cancer and its clinical significance.

Methods

The expression of CAV-1 and MMP-2 were detected by the SP immunohistochemical method in 77 cases of bladder cancer.

Results

The positive rates of CAV-1, MMP-2 in bladder transitional cell carcinoma (BTCC) and bladder adenocarcinoma were significantly high than those of normal bladder mucosa, the positive rates in the deeper cancer invasion was significantly high than those of superficial bladder cancer (P < 0.01), the positive rates of CAV-1 in grades I, II and III of bladder transitional cell carcinaoma (BTCC) were 15%, 40% and 68%, respectively; the positive rates of MMP-2 in grades I, II and III of bladder transitional cell carcinoma (BTCC) were 20%, 40% and 72%, respectively (P < 0.01). CAV-1 was positive associated with MMP-2 in bladder cancer (r = 0.598, P < 0.001), but not in bladder tissue.

Conclusion

CAV-1 and MMP-2 were associated with stage and grade of bladder cancer, which suggested that CAV-1 might improve secretion of MMP-2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ho CC, Huang PH, Huang HY, et al. Up-Regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. Am J Pathol, 2002, 161: 1647–1656.

    PubMed  CAS  Google Scholar 

  2. Joo HJ, Oh DK, Kim YS, et al. Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma. BJU Int, 2004, 93: 291–296.

    Article  PubMed  CAS  Google Scholar 

  3. Wiechen K, Diatchenko L, Agoulnik A. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate carcinoma suppressor. Gene Am J Pathol, 2001, 159: 1635–1643.

    CAS  Google Scholar 

  4. Abdel-Wahed MM, Asaad NY, Aleskandarany M. Expression of matrix metalloproteinase-2 in renal cell carcinoma. J Egypt Natl Canc Inst, 2004, 16: 168–177.

    PubMed  Google Scholar 

  5. Galvez BG, Matias-Roman S, Yanez Mo, et al. Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells. Mol Biol Cell, 2004, 15: 678–687.

    Article  PubMed  CAS  Google Scholar 

  6. Williams TM, Medina F, Badano I, et al. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem, 2004, 279: 51630–51646.

    Article  PubMed  CAS  Google Scholar 

  7. Yang G, Truong LD, Timme TL, et al. Elevated expression of caveolin is associated with prostate and breast cancer. Clin Cancer Res, 1998, 4: 1873–1880.

    PubMed  CAS  Google Scholar 

  8. Puyraimond A, Fridman R, Lemesle M, et al. MMP-2 colocalizes with caveolae on the surface of endothelial cells. Exp Cell Res, 2001, 262: 28–36.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hengping Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, H., Chen, Y. & Yan, D. Expression of caveolin-1 and MMP-2 in bladder cancer and its clinical significance. Chin.- Ger. J. Clin. Oncol. 6, 571–573 (2007). https://doi.org/10.1007/s10330-007-0114-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10330-007-0114-4

Key words

Navigation